Medicom Digital Has Sold Its Rx Savings Assistant® to ConnectiveRx
December 2022
Tamarack Partners advised Medicom Digital on the sale of its Rx Savings Assistant® to ConnectiveRx, a portfolio company of Genstar Capital. Terms of the deal were not disclosed.
Medicom Digital’s Rx Savings Assistant automatically finds prescription savings offers and embeds them into qualifying patient records where healthcare providers see the offers inside their EHR (electronic health record) workflow and deliver them to patients directly. Top tier health systems and hospitals across the U.S., including those that are integrated with Epic EHR systems, rely on Rx Savings Assistant for patient support.
With this acquisition, Rx Savings Assistant becomes part of ConnectiveRx’s EHR Network, which reaches inpatient and outpatient settings (physician offices, ambulatory health clinics, and hospital systems) with ScriptGuide® prescription savings coupons and other affordability-related offers at the point of care. As the largest EHR network aggregator, ConnectiveRx has the industry’s most expansive prescriber reach—supporting 720,000 healthcare providers and their patients.
ConnectiveRx takes the pain out of the prescription process for pharmaceutical manufacturers, healthcare providers, and patients. Through its software-enabled patient support and access solutions, ConnectiveRx maximizes the benefits of medications by accelerating speed-to-therapy and improving patient adherence. ConnectiveRx is headquartered in both Whippany, NJ and Pittsburgh, PA.
Genstar Capital is a private equity firm focused on investments in targeted segments of the financial services, healthcare, industrials, and software industries. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar currently has approximately $35 billion of assets under management.
Tamarack Partners provides M&A advisory services to owners of lower middle market companies. For more information on this transaction or to speak with one of our transactional advisors about your business, Contact Us.